HAMILTON LANE INC-CLASS A (HLNE) Stock Fundamental Analysis
NASDAQ:HLNE - Nasdaq - US4074971064 - Common Stock - Currency: USD
Overall HLNE gets a fundamental rating of 7 out of 10. We evaluated HLNE against 222 industry peers in the Capital Markets industry. HLNE gets an excellent profitability rating and is at the same time showing great financial health properties. HLNE is growing strongly while it is still valued neutral. This is a good combination! With these ratings, HLNE could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
HLNE had positive earnings in the past year.
In the past year HLNE had a positive cash flow from operations.
HLNE had positive earnings in each of the past 5 years.
Each year in the past 5 years HLNE had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 12.76%, HLNE belongs to the top of the industry, outperforming 92.63% of the companies in the same industry.
HLNE's Return On Equity of 29.97% is amongst the best of the industry. HLNE outperforms 96.77% of its industry peers.
The Return On Invested Capital of HLNE (22.22%) is better than 97.70% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HLNE is significantly above the industry average of 6.67%.
The 3 year average ROIC (19.34%) for HLNE is below the current ROIC(22.22%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.76% | ||
| ROE | 29.97% | ||
| ROIC | 22.22% |
ROA(3y)10.77%
ROA(5y)10.68%
ROE(3y)32.12%
ROE(5y)34.97%
ROIC(3y)19.34%
ROIC(5y)20.09%
1.3 Margins
Looking at the Profit Margin, with a value of 28.03%, HLNE is in the better half of the industry, outperforming 70.51% of the companies in the same industry.
In the last couple of years the Profit Margin of HLNE has grown nicely.
The Operating Margin of HLNE (45.03%) is better than 76.04% of its industry peers.
In the last couple of years the Operating Margin of HLNE has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 45.03% | ||
| PM (TTM) | 28.03% | ||
| GM | N/A |
OM growth 3Y-0.86%
OM growth 5Y1.44%
PM growth 3Y-2.38%
PM growth 5Y13.8%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
HLNE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for HLNE has been increased compared to 5 years ago.
The debt/assets ratio for HLNE has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 7.98 indicates that HLNE is not in any danger for bankruptcy at the moment.
The Altman-Z score of HLNE (7.98) is better than 93.55% of its industry peers.
The Debt to FCF ratio of HLNE is 1.12, which is an excellent value as it means it would take HLNE, only 1.12 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of HLNE (1.12) is better than 86.64% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that HLNE is not too dependend on debt financing.
The Debt to Equity ratio of HLNE (0.32) is better than 75.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.32 | ||
| Debt/FCF | 1.12 | ||
| Altman-Z | 7.98 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 0.92 indicates that HLNE may have some problems paying its short term obligations.
With a Current ratio value of 0.92, HLNE perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
A Quick Ratio of 0.92 indicates that HLNE may have some problems paying its short term obligations.
HLNE has a Quick ratio of 0.92. This is comparable to the rest of the industry: HLNE outperforms 42.86% of its industry peers.
HLNE does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 45.03% over the past year.
The Earnings Per Share has been growing by 15.47% on average over the past years. This is quite good.
The Revenue has grown by 31.89% in the past year. This is a very strong growth!
Measured over the past years, HLNE shows a quite strong growth in Revenue. The Revenue has been growing by 17.04% on average per year.
EPS 1Y (TTM)45.03%
EPS 3Y12.82%
EPS 5Y15.47%
EPS Q2Q%20.22%
Revenue 1Y (TTM)31.89%
Revenue growth 3Y17.48%
Revenue growth 5Y17.04%
Sales Q2Q%18.22%
3.2 Future
The Earnings Per Share is expected to grow by 15.12% on average over the next years. This is quite good.
HLNE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.12% yearly.
EPS Next Y27.02%
EPS Next 2Y17.51%
EPS Next 3Y17.31%
EPS Next 5Y15.12%
Revenue Next Year30.91%
Revenue Next 2Y19.67%
Revenue Next 3Y17.53%
Revenue Next 5Y17.12%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 34.09 indicates a quite expensive valuation of HLNE.
Based on the Price/Earnings ratio, HLNE is valued a bit more expensive than 71.89% of the companies in the same industry.
HLNE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.46.
Based on the Price/Forward Earnings ratio of 29.41, the valuation of HLNE can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HLNE indicates a slightly more expensive valuation: HLNE is more expensive than 71.89% of the companies listed in the same industry.
HLNE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 92.56.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.09 | ||
| Fwd PE | 29.41 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HLNE indicates a somewhat cheap valuation: HLNE is cheaper than 61.29% of the companies listed in the same industry.
HLNE's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 50.55 | ||
| EV/EBITDA | 29.23 |
4.3 Compensation for Growth
HLNE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
HLNE has an outstanding profitability rating, which may justify a higher PE ratio.
HLNE's earnings are expected to grow with 17.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.26
PEG (5Y)2.2
EPS Next 2Y17.51%
EPS Next 3Y17.31%
5. Dividend
5.1 Amount
HLNE has a Yearly Dividend Yield of 1.23%.
HLNE's Dividend Yield is slightly below the industry average, which is at 9.43.
With a Dividend Yield of 1.23, HLNE pays less dividend than the S&P500 average, which is at 2.27.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.23% |
5.2 History
On average, the dividend of HLNE grows each year by 26.37%, which is quite nice.
HLNE has been paying a dividend for over 5 years, so it has already some track record.
HLNE has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)26.37%
Div Incr Years7
Div Non Decr Years7
5.3 Sustainability
38.88% of the earnings are spent on dividend by HLNE. This is a low number and sustainable payout ratio.
HLNE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP38.88%
EPS Next 2Y17.51%
EPS Next 3Y17.31%
HAMILTON LANE INC-CLASS A
NASDAQ:HLNE (1/31/2025, 6:21:48 PM)
After market: 159.18 0 (0%)159.18
-0.28 (-0.18%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners95.57%
Inst Owner Change0.06%
Ins Owners4.89%
Ins Owner Change0.06%
Market Cap8.82B
Analysts51.67
Price Target195.16 (22.6%)
Short Float %4.24%
Short Ratio3.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.23% |
Yearly Dividend1.21
Dividend Growth(5Y)26.37%
DP38.88%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)15.68%
Min EPS beat(2)-3.63%
Max EPS beat(2)34.99%
EPS beat(4)2
Avg EPS beat(4)10.13%
Min EPS beat(4)-24.34%
Max EPS beat(4)34.99%
EPS beat(8)4
Avg EPS beat(8)1.55%
EPS beat(12)8
Avg EPS beat(12)11.8%
EPS beat(16)12
Avg EPS beat(16)16.48%
Revenue beat(2)1
Avg Revenue beat(2)11.46%
Min Revenue beat(2)-3.38%
Max Revenue beat(2)26.31%
Revenue beat(4)2
Avg Revenue beat(4)11%
Min Revenue beat(4)-5.87%
Max Revenue beat(4)26.94%
Revenue beat(8)3
Avg Revenue beat(8)5.06%
Revenue beat(12)5
Avg Revenue beat(12)8.85%
Revenue beat(16)8
Avg Revenue beat(16)8.23%
PT rev (1m)0%
PT rev (3m)15.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.28%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.01%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.09 | ||
| Fwd PE | 29.41 | ||
| P/S | 13.6 | ||
| P/FCF | 50.55 | ||
| P/OCF | 48.37 | ||
| P/B | 14.55 | ||
| P/tB | 14.55 | ||
| EV/EBITDA | 29.23 |
EPS(TTM)4.67
EY2.93%
EPS(NY)5.41
Fwd EY3.4%
FCF(TTM)3.15
FCFY1.98%
OCF(TTM)3.29
OCFY2.07%
SpS11.7
BVpS10.94
TBVpS10.94
PEG (NY)1.26
PEG (5Y)2.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.76% | ||
| ROE | 29.97% | ||
| ROCE | 28.15% | ||
| ROIC | 22.22% | ||
| ROICexc | 28.44% | ||
| ROICexgc | 29.96% | ||
| OM | 45.03% | ||
| PM (TTM) | 28.03% | ||
| GM | N/A | ||
| FCFM | 26.91% |
ROA(3y)10.77%
ROA(5y)10.68%
ROE(3y)32.12%
ROE(5y)34.97%
ROIC(3y)19.34%
ROIC(5y)20.09%
ROICexc(3y)21.93%
ROICexc(5y)22.96%
ROICexgc(3y)23.08%
ROICexgc(5y)24.14%
ROCE(3y)24.51%
ROCE(5y)25.46%
ROICexcg growth 3Y13.41%
ROICexcg growth 5Y-9.75%
ROICexc growth 3Y12.7%
ROICexc growth 5Y-9.54%
OM growth 3Y-0.86%
OM growth 5Y1.44%
PM growth 3Y-2.38%
PM growth 5Y13.8%
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.32 | ||
| Debt/FCF | 1.12 | ||
| Debt/EBITDA | 0.65 | ||
| Cap/Depr | 85.68% | ||
| Cap/Sales | 1.21% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 60.55% | ||
| Profit Quality | 96% | ||
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 7.98 |
F-Score9
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)117.78%
Cap/Depr(5y)203.85%
Cap/Sales(3y)1.73%
Cap/Sales(5y)2.64%
Profit Quality(3y)128.03%
Profit Quality(5y)149.17%
High Growth Momentum
Growth
EPS 1Y (TTM)45.03%
EPS 3Y12.82%
EPS 5Y15.47%
EPS Q2Q%20.22%
EPS Next Y27.02%
EPS Next 2Y17.51%
EPS Next 3Y17.31%
EPS Next 5Y15.12%
Revenue 1Y (TTM)31.89%
Revenue growth 3Y17.48%
Revenue growth 5Y17.04%
Sales Q2Q%18.22%
Revenue Next Year30.91%
Revenue Next 2Y19.67%
Revenue Next 3Y17.53%
Revenue Next 5Y17.12%
EBIT growth 1Y33.86%
EBIT growth 3Y16.47%
EBIT growth 5Y18.73%
EBIT Next Year42.54%
EBIT Next 3Y21.78%
EBIT Next 5Y22.57%
FCF growth 1Y-26.41%
FCF growth 3Y-13.33%
FCF growth 5Y0.67%
OCF growth 1Y-24.47%
OCF growth 3Y-13.73%
OCF growth 5Y1.61%